While GLP-1 medications like semaglutide can cost around $1,000 a month and come with potential side effects, allulose offers a promising food-based alternative without these drawbacks
Obesity, type 2 diabetes, lifestyle factors, and risk of gallstone disease: a Mendelian randomization investigation
Ozempic (semaglutide) Ozempic is FDA-approved , along with diet and exercise, for controlling blood sugar in adults with type 2 diabetes and reducing cardiovascular risks such as stroke, heart attack, and death from cardiovascular issues in adults with type 2 diabetes and heart disease
Wang G, Meyer JG, Cai W, Li ME, Softic S, Kahn CR